tiprankstipranks
Altimmune (ALT)
NASDAQ:ALT
Want to see ALT full AI Analyst Report?

Compare Altimmune (ALT) vs. Competitors

3,673 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Altimmune
$3.50
$579.53M
-4.20
-44.08%
5 Buy
2 Hold
0 Sell
Moderate Buy
Tvardi Therapeutics
$3.39
$30.96M
-2.12
-88.69%
3 Buy
2 Hold
1 Sell
Moderate Buy
Diamedica Therapeutics
$6.85
$328.69M
-9.44
48.08%
3 Buy
0 Hold
0 Sell
Strong Buy
Alpha Tau Medical Ltd
$8.03
$905.62M
-15.98
239.93%
3 Buy
1 Hold
0 Sell
Strong Buy
enGene Holdings
$8.07
$115.22M
-0.98
-55.39%
3 Buy
8 Hold
0 Sell
Moderate Buy
Lexeo Therapeutics, Inc.
$6.91
$399.68M
-4.71
85.40%
5 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
ALT
Altimmune
3.07
-2.54
-45.28%
TVRD
Tvardi Therapeutics
3.49
-26.37
-88.31%
DMAC
Diamedica Therapeutics
6.16
1.97
47.02%
DRTS
Alpha Tau Medical Ltd
10.13
7.13
237.67%
ENGN
enGene Holdings
1.78
-2.18
-55.05%
LXEO
Lexeo Therapeutics, Inc.
5.08
2.21
77.00%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts